z-logo
open-access-imgOpen Access
Protocol Biopsies in Patients With Subclinical De Novo Donor-specific Antibodies After Kidney Transplantation: A Multicentric Study
Author(s) -
Dominique Bertrand,
Philippe Gatault,
Maïté Jauréguy,
Cyril Garrouste,
Johnny Sayegh,
Nicolas Bouvier,
Sophie Caillard,
Luca Lanfranco,
Aliénor Galinier,
Charlotte Laurent,
Isabelle Étienne,
Fabienne Farce,
François Audigier,
Dominique Guerrot
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003055
Subject(s) - medicine , subclinical infection , biopsy , renal function , urology , kidney , donor specific antibodies , kidney transplantation , transplantation , renal biopsy , immunosuppression , proteinuria , gastroenterology , surgery
De novo donor-specific antibodies (DSAs) are associated with antibody-mediated rejection (AMR) and allograft loss. Whether monitoring of de novo DSA (dnDSA) paired with systematic kidney biopsy should become routine remains to be established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here